FDAnews Drug Daily Bulletin

PACIFIC BIOMETRICS, INC. AWARDED MAJOR RESEARCH CONTRACT

April 12, 2006
A A

Pacific Biometrics, Inc. has been awarded a series of contracts with a top multinational pharmaceutical company (the "Sponsor") to provide essential laboratory data for a global Phase I and Phase II cholesterol-treatment program. These contracts are part of a series of eight contracts related to clinical trials that form part of a global development program for an innovative approach for the prevention and treatment of dyslipidemia, atherosclerosis, and coronary heart disease. PBI will provide the Sponsor with cholesterol, lipid, and inflammatory marker testing on samples collected to support the Sponsor's clinical development program.
dBusinessNews